Free Trial

Theravance Biopharma (TBPH) SEC Filings & 10K Form

Theravance Biopharma logo
$9.52 -0.05 (-0.52%)
(As of 11/15/2024 ET)

Recent Theravance Biopharma SEC Filings

DateFilerForm TypeView
11/14/2024
8:53 AM
Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
11/14/2024
5:06 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:42 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:33 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
09/23/2024
5:05 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:02 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:42 PM
BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
08/22/2024
7:03 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:05 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:07 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:09 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:02 PM
Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:05 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:57 PM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
5:15 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:02 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:04 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:08 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:10 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
5:26 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:01 PM
Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:02 PM
BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:04 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:06 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:09 PM
MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:10 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:12 PM
PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:15 PM
Theravance Biopharma (Filer)
Form DEF 14A
04/04/2024
5:09 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:11 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:13 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:15 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:17 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:06 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:01 AM
Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
Form SC 13D/A
02/22/2024
7:04 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
02/22/2024
7:06 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:08 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:10 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:11 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:14 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:12 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2024
5:16 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:07 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
5:01 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
5:06 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2023
5:09 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:10 PM
Theravance Biopharma (Filer)
Form DEFA14A
12/21/2023
4:06 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
5:07 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:10 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:11 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:14 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
5:16 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:16 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TBPH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners